AMBRILIA BIOPHARMA INC.

Yahoo! Finance: AMB.TO NewsLatest Financial News for AMBRILIA BIOPHARMA INC

URL

XML feed
http://finance.yahoo.com/q/h?s=amb.to

Last update

4 min 7 sec ago

July 28, 2010

21:47
Ambrilia Biopharma Closes Initial Phase of a Transaction and Obtains Two Million Dollars of Non-Dilutive Financing (Marketwire)
MONTREAL, QUEBEC-- - Ambrilia Biopharma Inc. announced today that, as a result of the closing of the initial phase of the transaction disclosed on May 26, 2010, Ambrilia and its subsidiary Cellpep Pharma Inc. have obtained today non-dilutive financing of approximately $2M.
21:47
Ambrilia Biopharma Provides Bi-Weekly Update on its Status and Restructuring Efforts (Marketwire)
02:15
Ambrilia Appoints Mr. Faraj Nakhleh to its Board of Directors (Marketwire)
MONTREAL, QUEBEC-- - Ambrilia Biopharma Inc. is pleased to announce the appointment of Mr. Faraj Nakhleh, Eng., ICD,.D, to its Board of Directors, effective immediately.
02:15
Ambrilia Biopharma Provides Bi-Weekly Update on Its Status (Marketwire)

July 24, 2010

07:07
Ambrilia Biopharma Provides Bi-Weekly Update on Its Status (Marketwire)
MONTREAL, QUEBEC-- - Ambrilia Biopharma Inc. is providing today its bi-weekly Default Status Report under National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults .

July 22, 2010

14:04
Ambrilia Biopharma Obtains Court Approval of A Proposed Transaction (Marketwire)
14:04
Ambrilia Biopharma Announces Changes to Its Board of Directors (Marketwire)
04:43
Ambrilia Biopharma Provides Bi-Weekly Update on its Status (Marketwire)
04:43
Ambrilia Biopharma Obtains a Fourth Extension of CCAA Stay Order and Provides Bi-Weekly Update on Its Status (Marketwire)
04:43
SurModics Provides a Notice of Termination of a Product Licence Agreement (Marketwire)
04:43
Ambrilia Biopharma Provides Bi-Weekly Status Update (Marketwire)
04:43
Ambrilia Biopharma Provides Bi-Weekly Status Update (Marketwire)
04:43
Ambrilia Biopharma Provides Bi-Weekly Status Update (Marketwire)
03:37
Ambrilia Biopharma Obtains Fifth Extension of CCAA Stay Order, Court Approval of Amendment to Proposed Transaction and Provides Bi-Weekly Status Update (Marketwire)
MONTREAL, QUEBEC-- - Ambrilia Biopharma Inc. announced today that it obtained today a fifth order from the Superior Court of Quebec extending in its effect the initial order issued by the Court on July 31, 2009 covering Ambrilia and Cellpep Pharma Inc., its subsidiary, until September 30, 2010, the whole pursuant to the Companies' Creditors Arrangement Act .

July 21, 2010

23:19
Ambrilia Biopharma Provides Bi-Weekly Update on Its Status (Marketwire)
MONTREAL, QUEBEC-- -
23:19
Ambrilia Biopharma Provides Bi-Weekly Update on Its Status (Marketwire)
MONTREAL, QUEBEC-- -
20:00
Ambrilia Biopharma Provides Bi-Weekly Update on Its Status (Marketwire)
MONTREAL, QUEBEC-- -
20:00
Ambrilia Biopharma Provides Bi-Weekly Update on its Status (Marketwire)
MONTREAL, QUEBEC-- - Ambrilia Biopharma Inc. is providing today its bi-weekly Default Status Report under National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults .
07:56
Ambrilia Biopharma Provides Bi-Weekly Update on Its Status (Marketwire)
MONTREAL, QUEBEC-- - Ambrilia Biopharma Inc.